$MVST

Microvast Holdings, Inc. (MVST): Results of Operations and Financial Condition

Microvast Holdings, Inc. (MVST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mvst2026q2ex991earningspre.htm EX-99.1 Document Exhibit 99.1 Microvast Reports Second Quarter 2026 Financial Results Houston, Texas, USA — Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” or the “Company”), a global leader in advanced battery technologies, announced

Original reporting
Published Aug 11, 2026, 1:20 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MVST
Neutral
medium confidence
Mentioned
$MVST
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MVSTNeutralMed
01

Why it matters

Traders can reassess near-term fundamentals using the reported revenue decline, gross margin compression, higher operating expenses, cash balance change, and capex level, alongside the stated 2026 production and localization milestones.

02

Market read

This is a primary earnings-style disclosure with concrete quarterly numbers and operational milestones that can drive estimates for margin, utilization, and cash needs into year-end.

03

What to watch

Gross margin fell materially and adjusted EBITDA turned much weaker year over year, so the key swing factor is whether Phase 3.2 ramp-up and Clarksville localization actually improve utilization and absorption by year-end.

Relevance 7/10Novelty 7/10Timing: post-market filing on Aug 10, 2026 for Q2 2026 results

Background

Microvast filed an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting unaudited Q2 2026 financial results and operational updates.

Company-level read

Ticker impact

$MVSTNeutralMedium confidence
Context

Microvast reports Q2 2026 results with $87.3M revenue, 29.5% gross margin, and a net loss of $12.0M, plus 2026 capacity ramp milestones.

Expected impact

Near-term volatility likely around gross margin and cash burn versus ramp progress, with upside sensitivity to Phase 3.2 and domestic pack-line timing.

Evidence & confidence

This is a primary SEC 8-K earnings release with specific datapoints (revenue, margin, net loss, cash, capex) and stated 2026 milestones, but it does not include explicit forward revenue or margin targets beyond a stable gross margin goal.

Market effects

EV battery supply chain names may see read-through on utilization and raw-material cost pressure, plus demand mix between commercial and transit markets.

Highlights regulatory and geopolitical demand shifts in India and Korea, which can influence regional battery demand expectations.

Tariff refund mechanics tied to IEEPA rulings may affect cross-border battery import economics for other manufacturers.

Counterpoint

The tariff refund and reduced fair-value losses may make the quarter look better than underlying operating momentum, so investors may discount the improvement.

Key entities

  • Microvast Holdings, Inc.

    Reports Q2 2026 financial results and 2026 outlook tied to Phase 3.2 capacity ramp and Clarksville pack-line localization.

  • IEEPA tariff refunds

    Supreme Court ruling enables refunds; Microvast notes $2.7M of refunds issued to a customer reduced revenue in Q2 2026.

  • Huzhou Phase 3.2

    Capacity expansion expected to deliver up to 2 GWh of next-generation modular capacity in 2026.

  • Clarksville pack line localization

    Localized pack assembly initial operations anticipated by year-end.

Related articles

$HIVEMedAI 8/10

HIVE Digital Technologies Ltd.: HIVE Reports Q1 2027 Revenue of $79.1 Million; Contracted GPU Cloud ARR(1) Reaches Approximately $110 million

HIVE Digital Technologies reported Q1 FY2027 revenue of $79.1 million, up 73.5% year over year, with digital currency revenue of $72.1 million and HPC revenue of $7.1 million. Contracted GPU cloud ARR rose to about $110 million. Cash and digital currencies totaled $219.2 million. GAAP net loss was $142.9 million, including a $84.7 million Swedish VAT provision.

$HSDTMed

Solana Company Q2 Loss Hits $30.3 Million as SOL Treasury Suffers

Solana Company (Nasdaq: HSDT) reported a Q2 net loss of $30.3 million, driven by write-downs on its SOL treasury holdings, while revenue was $2.5 million. The firm said staking generated most revenue. Shares fell 5.56% to $1.70. Assets were $176.1 million, with long-term digital assets $147.3 million.

$RMDMed

Why You Should Consider Buying ResMed Stock After Its First-Ever Annual Guide

ResMed (RMD) issued its first full annual guidance for FY27, targeting $5.75B to $5.85B revenue and non-GAAP EPS of $12.00 to $12.25, with 5% to 7% core constant-currency revenue growth and 12% to 14% core EPS growth after an Astral ventilator sales suspension. Q4 results included $1.5B revenue and $2.95 non-GAAP EPS. Analysts’ mean target is $247.20 vs. $224.46 close.

$REAXMedAI 8/10

Real (REAX) Q2 2026 Earnings Call Transcript

Real Brokerage (NASDAQ:REAX) reported Q2 2026 revenue of $700.6 million, up 30% year over year, driven by higher transaction volumes. Non-GAAP adjusted EBITDA rose 38% to $27.6 million. Net loss was $8 million, including $11.6 million acquisition costs tied to the pending RE/MAX deal. Management guided for sequential Q3 revenue and EBITDA declines due to seasonality.

$RMBSMedAI 8/10

Rambus Inc (RMBS) Stock News & Articles

Rambus (RMBS) reported Q2 2026 results after the bell. EPS was $0.77 versus $0.71 expected, and revenue was $207M versus $198M expected. The company cited record product revenue up 22% year over year, driven by AI data center demand, and said Q3 guidance indicates continued momentum.